MedTrace Logo

Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.

NCT00708513 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2013-10-21

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the safety and benefit of auto-transfusion filtered blood in patients undergoing major surgical oncology procedures.

Conditions

  • Pancreaticoduodenectomy
  • Pancreatectomy
  • Esophagectomy
  • Gastrectomy
  • Hepatectomy

Sponsors & Collaborators

  • University of Louisville

    lead OTHER

Principal Investigators

  • Robert CG Martin, MD · University of Louisville

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-12-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00708513 on ClinicalTrials.gov